C07H 19/044
Pyrrole radicals
C07H19/044 (Pyrrole radicals) appears on 93 US grants and 61 published applications in this corpus.
Search patents in C07H- Granted patents
- 93
- Published applications
- 61
- Assignees
- 73
- Inventors
- 263
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 5 | 0 |
| 1996 | 3 | 0 |
| 1997 | 10 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 1 | 1 |
| 2003 | 4 | 7 |
| 2004 | 1 | 6 |
| 2005 | 3 | 1 |
| 2006 | 2 | 2 |
| 2007 | 0 | 2 |
| 2008 | 1 | 1 |
| 2009 | 1 | 2 |
| 2010 | 0 | 2 |
| 2011 | 2 | 2 |
| 2012 | 0 | 1 |
| 2013 | 0 | 4 |
| 2014 | 7 | 6 |
| 2015 | 5 | 4 |
| 2016 | 2 | 5 |
| 2017 | 2 | 2 |
| 2018 | 1 | 1 |
| 2019 | 2 | 2 |
| 2020 | 1 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 2 | 1 |
| 2024 | 2 | 4 |
| 2025 | 2 | 4 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- ASGPR-binding compounds for the degradation of extracellular proteins30 Jun 2026US 12,667,620 B2Avilar Therapeutics, Inc.
- ASGPR-binding compounds for the degradation of extracellular proteins12 May 2026US 12,622,972 B2Avilar Therapeutics, Inc.
- ASGPR-binding compounds for the degradation of extracellular proteins6 May 2025US 12,290,568 B2Avilar Therapeutics, Inc.
- ASGPR-binding compounds for the degradation of extracellular proteins22 Apr 2025US 12,280,116 B2Avilar Therapeutics, Inc.
- ASGPR-binding compounds for the degradation of extracellular proteins29 Oct 2024US 12,128,106 B2Avilar Therapeutics, Inc.
- Asgpr-binding compounds for the degradation of extracellular proteins6 Nov 2025US 2025/0339541 A1Avilar Therapeutics, Inc.
- Asgpr-binding compounds for the degradation of extracellular proteins3 Jul 2025US 2025/0213699 A1Avilar Therapeutics, Inc.
- Sulfinate glycosyl donor, method for preparing same, and use thereof20 Feb 2025US 2025/0059226 A1Sichuan University
- Method for preparing aryl carbon glycoside compound including gliflozin drug6 Feb 2025US 2025/0042930 A1Sichuan University
- Asgpr-binding compounds for the degradation of extracellular proteins26 Dec 2024US 2024/0424108 A1Avilar Therapeutics, Inc.
Most cited
By later US patents
- Substituted pyrroles122US 5,057,614 AHoffmann-La Roche Inc. · 1991
- Nucleoside analogues119US 6,239,159 B1Amersham Pharmacia Biotech UK Limited · 2001
- Method for sequencing DNA and RNA by synthesis106US 7,544,794 B12009
- C-4' modified adenosine kinase inhibitors101US 5,763,596 AMetabasis Therapeutics, Inc. · 1998
- Modified oligonucleotides, their preparation and their use67US 5,844,106 AHoechst Aktiengesellschaft · 1998